NCT04124081View on ClinicalTrials.gov

Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

June 15, 2019

Study Completion Date

August 13, 2019

Conditions
Hydronidone
Interventions
DRUG

Hydronidone capsules& Entecavir capsules

take the Hydronidone capsule and then the entecavir capsule, and then take the last two together

Trial Locations (1)

430030

Ethics committee of drug clinical trials of huazhong university of science and technology, Wuhan

All Listed Sponsors
lead

Beijing Continent Pharmaceutical Co, Ltd.

INDUSTRY

NCT04124081 - Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter